Spotlight -

Long-Acting Injectable Therapy in the Management of Adult Patients with Schizophrenia|

Major Depressive Disorder

Jaclyn Halpern, PsyD

Dr Halpern is the Director of the SOAR program at Washington Behavioral Medicine Associates.

Articles by Jaclyn Halpern, PsyD

What are the unique challenges for individuals with ADHD?

ADHD and the COVID-19 Pandemic

ByJaclyn Halpern, PsyD ,Gonzalo Laje, MD, FAPA

May 10th 2022

What are the unique challenges for individuals with ADHD?

Concerning Content: TikTok’s Effect on Child and Adolescent Mental Health

ByLeah Kuntz,Jaclyn Halpern, PsyD

March 11th 2022

TikTok has over 1 billion users and dominates youth culture. But is it damaging their mental health?

Latest Updated Articles

Trending on Psychiatric Times

ADHD Found Connected to Substance Use Disorder, With Sex Prevalence Differences

Recognizing the Neuropsychiatric Symptoms of Huntington Disease

New ECNP Poster Data on Adjunctive Lumateperone for Major Depressive Disorder

Today Is World Mental Health Day: How Is Yours?

"The Harvest"

© 2025 MJH Life Sciences^®

All rights reserved.